These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 19818171)
1. Understanding the pharmacokinetics of Coartem. Djimdé A; Lefèvre G Malar J; 2009 Oct; 8 Suppl 1(Suppl 1):S4. PubMed ID: 19818171 [TBL] [Abstract][Full Text] [Related]
2. Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects. Abdulla S; Amuri B; Kabanywanyi AM; Ubben D; Reynolds C; Pascoe S; Fitoussi S; Yeh CM; Nuortti M; Séchaud R; Kaiser G; Lefèvre G Malar J; 2010 Sep; 9():253. PubMed ID: 20815879 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem) for bioequivalence in a randomized, open-label, two-period study. Lefèvre G; Bhad P; Jain JP; Kalluri S; Cheng Y; Dave H; Stein DS Malar J; 2013 Sep; 12():312. PubMed ID: 24010572 [TBL] [Abstract][Full Text] [Related]
4. Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®). Tiono AB; Tinto H; Alao MJ; Meremikwu M; Tshefu A; Ogutu B; Ouedraogo A; Lingani M; Cousin M; Lefèvre G; Jain JP; Duparc S; Hamed K Malar J; 2015 Apr; 14():157. PubMed ID: 25886021 [TBL] [Abstract][Full Text] [Related]
5. The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria. Borrmann S; Sallas WM; Machevo S; González R; Björkman A; Mårtensson A; Hamel M; Juma E; Peshu J; Ogutu B; Djimdé A; D'Alessandro U; Marrast AC; Lefèvre G; Kern SE Trop Med Int Health; 2010 Apr; 15(4):434-41. PubMed ID: 20180933 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects. Lefèvre G; Carpenter P; Souppart C; Schmidli H; McClean M; Stypinski D Br J Clin Pharmacol; 2002 Nov; 54(5):485-92. PubMed ID: 12445027 [TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria. Salman S; Page-Sharp M; Griffin S; Kose K; Siba PM; Ilett KF; Mueller I; Davis TM Antimicrob Agents Chemother; 2011 Nov; 55(11):5306-13. PubMed ID: 21876056 [TBL] [Abstract][Full Text] [Related]
8. Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator's product. Minzi OM; Marealle IA; Shekalaghe S; Juma O; Ngaimisi E; Chemba M; Rutaihwa M; Abdulla S; Sasi P Malar J; 2013 May; 12():174. PubMed ID: 23718725 [TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria. McGready R; Stepniewska K; Lindegardh N; Ashley EA; La Y; Singhasivanon P; White NJ; Nosten F Eur J Clin Pharmacol; 2006 Dec; 62(12):1021-31. PubMed ID: 17053895 [TBL] [Abstract][Full Text] [Related]
10. Coartem: the journey to the clinic. Premji ZG Malar J; 2009 Oct; 8 Suppl 1(Suppl 1):S3. PubMed ID: 19818170 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria. Djimdé AA; Tekete M; Abdulla S; Lyimo J; Bassat Q; Mandomando I; Lefèvre G; Borrmann S; Antimicrob Agents Chemother; 2011 Sep; 55(9):3994-9. PubMed ID: 21670177 [TBL] [Abstract][Full Text] [Related]
12. Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults. Byakika-Kibwika P; Lamorde M; Mayito J; Nabukeera L; Namakula R; Mayanja-Kizza H; Katabira E; Ntale M; Pakker N; Ryan M; Hanpithakpong W; Tarning J; Lindegardh N; de Vries PJ; Khoo S; Back D; Merry C J Antimicrob Chemother; 2012 Sep; 67(9):2213-21. PubMed ID: 22687893 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. Ezzet F; Mull R; Karbwang J Br J Clin Pharmacol; 1998 Dec; 46(6):553-61. PubMed ID: 9862244 [TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania. Mosha D; Guidi M; Mwingira F; Abdulla S; Mercier T; Decosterd LA; Csajka C; Genton B Antimicrob Agents Chemother; 2014 Aug; 58(8):4583-92. PubMed ID: 24867986 [TBL] [Abstract][Full Text] [Related]
16. A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya. Juma EA; Obonyo CO; Akhwale WS; Ogutu BR Malar J; 2008 Dec; 7():262. PubMed ID: 19102746 [TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania. Hietala SF; Mårtensson A; Ngasala B; Dahlström S; Lindegårdh N; Annerberg A; Premji Z; Färnert A; Gil P; Björkman A; Ashton M Antimicrob Agents Chemother; 2010 Nov; 54(11):4780-8. PubMed ID: 20713675 [TBL] [Abstract][Full Text] [Related]
18. Coartemether (artemether and lumefantrine): an oral antimalarial drug. Wernsdorfer WH Expert Rev Anti Infect Ther; 2004 Apr; 2(2):181-96. PubMed ID: 15482185 [TBL] [Abstract][Full Text] [Related]
19. Interaction trial between artemether-lumefantrine (Riamet) and quinine in healthy subjects. Lefèvre G; Carpenter P; Souppart C; Schmidli H; Martin JM; Lane A; Ward C; Amakye D J Clin Pharmacol; 2002 Oct; 42(10):1147-58. PubMed ID: 12362930 [TBL] [Abstract][Full Text] [Related]